LYON, FRANCE -- June 27, 2004 -- DrugAbuse Sciences SAS in Lyon, France, today announced the closing of a convertible bridge loan financing of 5 Million Euros to DrugAbuse Sciences SAS provided by its existing shareholders. All major existing shareholders of DrugAbuse Sciences SAS, including 3i, Alpinvest, Canaan Partners, CDC Innovation, Nomura Phase IV Ventures, Philippe Pouletty, and CDC have taken part in this financing.
